Bruyère Health is proud to stand among the hospitals, universities, and colleges in the region, highlighting the strength of Ottawa’s health and life science research environment.
Load More
A coalition of Canada's top dementia experts will test the Foresight™ platform by Canadian-based Perceiv Research Inc.
National Art Exhibition Inspires Canadian Artists to Reimagine the End of Life
Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.
Four knowledge brokers share how collaboration is at the heart of evidence-based care
An international team of researchers has received $1 million to launch one of the largest multinational studies to date examining how cardiovascular health influences the risk of Alzheimer’s disease and related dementias.
New research published in Palliative Care and Social Practice shows that food is much more than fuel for palliative patients.
The newly released Equity Extension to the STROBE Guideline published in The BMJ and JAMA Network Open covers a critical gap in the original guidelines.
Bruyère Health Research Institute has been redesignated as a PAHO/WHO Collaborating Centre and selected as a participant of the newly established WHO Health Inequality Monitoring Network.